Guangzhou Pharmaceutical (PK)【GZPHF】銘柄情報

Guangzhou Pharmaceutical Company Ltd (PK) (GZPHF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.34

( - )

買値

1.63

売値

2.09

出来高

0.00 日の範囲 0.00

2.14 52 週間の範囲 2.64

時価総額

3.804B

前日終値

2.34

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 10,031,122

発行済株式数

1,625,790,949

配当利回り

0.85 (4.19%)

PER

11.47

1 株当たり利益 (EPS)

1.81

歳入

78.46B

純利益

2.95B

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Busin... Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, production, and sale of health products; and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices. The company also offers bio-innovation, consumer health, and medical services; Xiaochaihu granules; Qingkailing and Baoji, Xia Sangju product series; Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills; compound Danshen and Naoxinqing tablet series; Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series; and honey-processed Chuanbei and Shedan Chuanbei loquat syrup. In addition, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics; Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk; and advertising services. Further, the company engages in the medical research industry; technology services industry; leasing and business services; and scientific research and technical services industry. It operates through hospitals, community healthcare facilities, and retail outlets through distributors and agents. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.gybys.com.cn

本社

Guangzhou, China

設立

1997

Guangzhou Pharmaceutical Company Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker GZPHF. The last closing price for Guangzhou Pharmaceutical (PK) was US$2.34. Over the last year, Guangzhou Pharmaceutical (PK) shares have traded in a share price range of US$ 2.14 to US$ 2.64.

Guangzhou Pharmaceutical (PK) currently has 1,625,790,949 shares in issue. The market capitalisation of Guangzhou Pharmaceutical (PK) is US$3.80 billion. Guangzhou Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 11.47.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	2.34	2.34	2.34	0	0	CS
26	0	0	2.34	2.34	2.34	43	2.34	CS
52	0.11	4.93273542601	2.23	2.64	2.14	2791	2.34233735	CS
156	-0.54	-18.75	2.88	2.88	2.14	3004	2.34302382	CS
260	-0.63	-21.2121212121	2.97	3.14	1.6065	1431	2.35989306	CS